Cytek Biosciences, based in Fremont, California, develops cell analysis solutions centred on flow cytometry and single-cell analysis. The company's patented Full Spectrum Profiling (FSP) technology forms the foundation of an integrated platform comprising instruments, software, reagents, and services designed to deliver high-resolution, high-content and high-sensitivity cellular analysis.
The company's product suite includes the Aurora, Northern Lights, and Aurora CS systems, positioned as streamlining workflows whilst generating high-parametric datasets for rapid biological insight. These solutions serve applications across immunology, oncology, cell therapy, and broader life sciences research, supporting both research studies and clinical applications.
Cytek's customer base encompasses leading pharmaceutical companies, contract research organisations, and academic research institutions worldwide. The company positions itself as enabling researchers to accelerate breakthroughs in healthcare and medicine through scientific innovation.
